TREATMENT STRATEGIES FOR SPINAL MUSCULAR ATROPHY

被引：4

作者：

Fuller, Heidi R. ^{[1
,2
]}

Barisic, Marija ^{[3
]}

Seso-Simic, Durdica ^{[4
]}

Speljko, Tea ^{[5
]}

Morris, Glenn E. ^{[1
,2
]}

Simic, Goran ^{[5
]}

机构：

[1] RJAH Orthopaed Hosp, Wolfson Ctr Inherited Neuromuscular Dis, Oswestry, Shrops, England

[2] Keele Univ, Inst Sci & Technol Med, Keele, Staffs, England

[3] Univ Hosp Ctr Zagreb, Dept Ophthalmol, Zagreb, Croatia

[4] Zagreb E Med Ctr, Dept Paediat, Zagreb, Croatia

[5] Univ Zagreb, Sch Med, Dept Neurosci, Croatian Inst Brain Res, Zagreb 41001, Croatia

来源：

TRANSLATIONAL NEUROSCIENCE | 2010年 / 1卷 / 04期

关键词：

Clinical trials; Spinal muscular atrophy; SMN1; gene; SMN2; SMN protein; Treatment; Therapy; SURVIVAL MOTOR-NEURON; THYROTROPIN-RELEASING-HORMONE; SMN2; GENE-EXPRESSION; PLACEBO-CONTROLLED TRIAL; VALPROIC ACID INCREASES; SURROGATE END-POINTS; SEVERE MOUSE MODEL; STEM-CELLS; MESSENGER-RNA; IN-VITRO;

D O I：

10.2478/v10134-010-0045-4

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Progress in understanding the genetic basis and pathophysiology of spinal muscular atrophy (SMA), along with continuous efforts in finding a way to increase survival motor neuron (SMN) protein levels have resulted in several strategies that have been proposed as potential directions for efficient drug development. Here we provide an overview on the current status of the following approaches: 1) activation of SMN2 gene and increasing full length SMN2 transcript level, 2) modulating SMN2 splicing, 3) stabilizing SMN mRNA and SMN protein, 4) development of neurotrophic, neuroprotective and anabolic compounds and 5) stem cell and gene therapy. The new preclinical advances warrant a cautious optimism for emergence of an effective treatment in the very near future.

引用

页码：308 / 321

页数：14

共 157 条

[91] SALBUTAMOL, A BETA-2-ADRENOCEPTOR AGONIST, INCREASES SKELETAL-MUSCLE STRENGTH IN YOUNG MEN [J].

MARTINEAU, L ;

HORAN, MA ;

ROTHWELL, NJ ;

LITTLE, RA .

CLINICAL SCIENCE, 1992, 83 (05) :615-621

[92] Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts [J].

Mattis, Virginia B. ;

Rai, Ravi ;

Wang, Jinhua ;

Chang, Cheng-Wei T. ;

Coady, Tristan ;

Lorson, Christian L. .

HUMAN GENETICS, 2006, 120 (04) :589-601

[93] Delivery of a read-through inducing compound, TC007, lessens the severity of a spinal muscular atrophy animal model [J].

Mattis, Virginia B. ;

Ebert, Allison D. ;

Fosso, Marina Y. ;

Chang, Cheng-Wei ;

Lorson, Christian L. .

HUMAN MOLECULAR GENETICS, 2009, 18 (20) :3906-3913

[94] Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number [J].

McAndrew, PE ;

Parsons, DW ;

Simard, LR ;

Rochette, C ;

Ray, PN ;

Mendell, JR ;

Prior, TW ;

Burghes, AHM .

AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 60 (06) :1411-1422

[95] Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy [J].

Mercuri, E. ;

Bertini, E. ;

Messina, S. ;

Solari, A. ;

D'Amico, A. ;

Angelozzi, C. ;

Battini, R. ;

Berardinelli, A. ;

Boffi, P. ;

Bruno, C. ;

Cini, C. ;

Colitto, F. ;

Kinali, M. ;

Minetti, C. ;

Mongini, T. ;

Morandi, L. ;

Neri, G. ;

Orcesi, S. ;

Pane, M. ;

Pelliccioni, M. ;

Pini, A. ;

Tiziano, F. D. ;

Villanova, M. ;

Vita, G. ;

Brahe, C. .

NEUROLOGY, 2007, 68 (01) :51-55

[96] Reliability of the Hammersmith functional motor scale for spinal muscular atrophy in a multicentric study [J].

Mercuri, E ;

Messina, S ;

Battini, R ;

Berardinelli, A ;

Boffi, P ;

Bono, R ;

Bruno, C ;

Carboni, N ;

Cini, C ;

Colitto, F ;

D'Amico, A ;

Minetti, C ;

Mirabella, M ;

Mongini, T ;

Morandi, L ;

Dlamini, N ;

Orcesi, S ;

Pelliccioni, M ;

Pane, M ;

Pini, A ;

Swan, AV ;

Villanova, M ;

Vita, G ;

Main, A ;

Muntoni, F ;

Bertini, E .

NEUROMUSCULAR DISORDERS, 2006, 16 (02) :93-98

[97] Pilot trial of phenylbutyrate in spinal muscular atrophy [J].

Mercuri, E ;

Bertini, E ;

Messina, S ;

Pelliccioni, M ;

D'Amico, A ;

Colitto, F ;

Mirabella, M ;

Tiziano, FD ;

Vitali, T ;

Angelozzi, C ;

Kinali, M ;

Main, M ;

Braheg, C .

NEUROMUSCULAR DISORDERS, 2004, 14 (02) :130-135

[98] Motor function-muscle strength relationship in spinal muscular atrophy [J].

Merlini, L ;

Bertini, E ;

Minetti, C ;

Mongini, T ;

Morandi, L ;

Angelini, C ;

Vita, G .

MUSCLE & NERVE, 2004, 29 (04) :548-552

[99] Role of gabapentin in spinal muscular atrophy: Results of a multicenter, randomized Italian study [J].

Merlini, L ;

Solari, A ;

Vita, G ;

Bertini, E ;

Minetti, C ;

Mongini, T ;

Mazzoni, E ;

Angelini, C ;

Morandi, L .

JOURNAL OF CHILD NEUROLOGY, 2003, 18 (08) :537-541

[100] Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation [J].

Meyer, Kathrin ;

Marquis, Julien ;

Trueb, Judith ;

Nlend, Rachel Nlend ;

Verp, Sonia ;

Ruepp, Marc-David ;

Imboden, Hans ;

Barde, Isabelle ;

Trono, Didier ;

Schuemperli, Daniel .

HUMAN MOLECULAR GENETICS, 2009, 18 (03) :546-555

← 5 6 7 8 9 10 11 12 13 14 →